PMC:7600245 / 8066-8205 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7600245","sourcedb":"PMC","sourceid":"7600245","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7600245","text":" parenterally administered drug is being developed by Gilead Sciences, U.S., and has broad-spectrum antiviral activity [26]. It was first s","tracks":[{"project":"LitCovid-PD-CLO","denotations":[{"id":"T47","span":{"begin":81,"end":84},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T48","span":{"begin":110,"end":118},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"attributes":[{"subj":"T47","pred":"source","obj":"LitCovid-PD-CLO"},{"subj":"T48","pred":"source","obj":"LitCovid-PD-CLO"}]},{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T61","span":{"begin":27,"end":31},"obj":"Chemical"},{"id":"T62","span":{"begin":100,"end":109},"obj":"Chemical"}],"attributes":[{"id":"A61","pred":"chebi_id","subj":"T61","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A62","pred":"chebi_id","subj":"T62","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"subj":"T61","pred":"source","obj":"LitCovid-PD-CHEBI"},{"subj":"T62","pred":"source","obj":"LitCovid-PD-CHEBI"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-CLO","color":"#ecb893","default":true},{"id":"LitCovid-PD-CHEBI","color":"#9e93ec"}]}]}}